FDA approves RSV vaccine for older adults
Published
The Food and Drug Administration on Wednesday approved Pfizer's vaccine against respiratory syncytial virus for people aged 60 and older, making it the second RSV shot authorized for use in the U.S. Why it matters: With the earlier approval of GlaxoSmithKline's RSV vaccine, older adults could soon…
#pfizer #rsv #glaxosmithkline #cdc #gsk #annaliesaanderson #fda #sanofi #astrazeneca